AR046598A1 - Vectores retrovirales para la administracion de arn de interferencia - Google Patents

Vectores retrovirales para la administracion de arn de interferencia

Info

Publication number
AR046598A1
AR046598A1 ARP040103824A ARP040103824A AR046598A1 AR 046598 A1 AR046598 A1 AR 046598A1 AR P040103824 A ARP040103824 A AR P040103824A AR P040103824 A ARP040103824 A AR P040103824A AR 046598 A1 AR046598 A1 AR 046598A1
Authority
AR
Argentina
Prior art keywords
target gene
retroviral vector
double stranded
stranded rna
antisense
Prior art date
Application number
ARP040103824A
Other languages
English (en)
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of AR046598A1 publication Critical patent/AR046598A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/867—Retroviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se proporcionan vectores retrovirales para administrar ARN de interferencia en células así como células infectadas por dichos vectores, las cuales tienen un oncogen como gen objetivo en su genoma. Reivindicación 1: Un vector retroviral para llevar un insecto especifico del gen objetivo en una célula a fin de modificar la expresión de un gen objetivo, que comprende: (a) un promotor; (b) una región poliligante; (c) un insecto especifico del gen objetivo que comprende ARN de doble hebra, en donde dicho ARN de doble hebra comprende una porción sentido que es complementaria a una porción de la hebra antisentido del gen objetivo, y una porción antisentido que es complementaria a la porción sentido, de modo que la porción sentido y la porción antisentido se hibridan, y el ARN de doble hebra se pliega para atrás sobre si mismo. Reivindicación 8: El vector retroviral de acuerdo con la Reivindicación 1, en el cual el vector retroviral es un virus de célula pluripotente murino (MSCV, abreviatura del ingles "Murine Stem Cell Virus"). Reivindicación 9: El vector retroviral de acuerdo con la Reivindicación 1, en el cual el vector retroviral es un Lentivirus modificado en el cual: (a) el promotor de CMV endógeno del Lentivirus ha sido eliminado; y (b) un elemento REV que se une a un elemento de respuesta REV (RRE, abreviatura del ingles "REV response element") es insertado.
ARP040103824A 2003-10-22 2004-10-21 Vectores retrovirales para la administracion de arn de interferencia AR046598A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51331303P 2003-10-22 2003-10-22

Publications (1)

Publication Number Publication Date
AR046598A1 true AR046598A1 (es) 2005-12-14

Family

ID=34549264

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103824A AR046598A1 (es) 2003-10-22 2004-10-21 Vectores retrovirales para la administracion de arn de interferencia

Country Status (13)

Country Link
US (2) US7612195B2 (es)
EP (1) EP1678312A1 (es)
JP (1) JP2007508842A (es)
KR (1) KR20060107519A (es)
CN (1) CN1871356B (es)
AR (1) AR046598A1 (es)
AU (2) AU2004286231B2 (es)
BR (1) BRPI0415646A (es)
CA (1) CA2542871C (es)
IL (1) IL174804A0 (es)
MX (1) MXPA06004428A (es)
TW (2) TWI350311B (es)
WO (1) WO2005042754A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006082385A1 (en) * 2005-02-01 2006-08-10 Medical Research Council Screening method
US20090217397A1 (en) * 2006-06-12 2009-08-27 Patrick Stern Cre-lox based gene knockdown constructs and methods of use thereof
US9043994B2 (en) 2007-03-13 2015-06-02 Massachusetts Institute Of Technology Cre-lox based gene knockdown constructs and methods of use thereof
EP2329024A4 (en) * 2008-08-25 2012-02-22 Inst Basic Med Sciences Pla ENDOGENOUS SHORT HAIR NADEL RNA AND ITS USE
US9481895B2 (en) 2011-09-23 2016-11-01 Ge Healthcare Dharmacon, Inc. Introduction of modular vector elements during production of a lentivirus
CN103060374B (zh) * 2012-10-30 2014-05-07 中国农业科学院兰州兽医研究所 一种基于位点特异性重组的rna干扰载体及其构建方法和应用
CN105586360A (zh) * 2016-03-04 2016-05-18 武汉科技大学 一种同时表达小分子rna和蛋白质的双功能慢病毒表达载体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624803A (en) * 1993-10-14 1997-04-29 The Regents Of The University Of California In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom
US6624803B1 (en) * 1995-10-20 2003-09-23 Wisconsin Alumni Research Foundation Interface for electronic devices providing improved access for people with disabilities
CN1429911A (zh) * 2001-12-30 2003-07-16 李卫云 慢病毒载体系统，产生载体的方法及其应用
US20040248296A1 (en) * 2002-03-20 2004-12-09 Beresford Paul J. HIV therapeutic
AU2003268546A1 (en) * 2002-09-06 2004-03-29 Massachusetts Institute Of Technology Lentiviral vectors, related reagents, and methods of use thereof
AU2003297474A1 (en) * 2002-12-18 2004-07-14 Salk Institute For Biological Studies Methods of inhibiting gene expression by rna interference

Also Published As

Publication number Publication date
CA2542871A1 (en) 2005-05-12
US7884200B2 (en) 2011-02-08
KR20060107519A (ko) 2006-10-13
AU2009248456B2 (en) 2011-09-15
TWI350311B (en) 2011-10-11
US20060252153A1 (en) 2006-11-09
AU2004286231A1 (en) 2005-05-12
AU2004286231B2 (en) 2009-09-10
BRPI0415646A (pt) 2006-12-12
TW201111508A (en) 2011-04-01
US7612195B2 (en) 2009-11-03
WO2005042754A1 (en) 2005-05-12
CA2542871C (en) 2010-11-16
AU2009248456A1 (en) 2010-01-07
IL174804A0 (en) 2006-08-20
EP1678312A1 (en) 2006-07-12
CN1871356B (zh) 2011-04-27
CN1871356A (zh) 2006-11-29
TW200523362A (en) 2005-07-16
JP2007508842A (ja) 2007-04-12
MXPA06004428A (es) 2006-07-03
US20100028996A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
ES2962434T3 (es) Procedimientos y composiciones para editar ARN
ES2628535T3 (es) Procedimiento y medicamento para la inhibición de la expresión de un gen predeterminado
HRP20190825T1 (hr) Regulacija genske ekspresije posredovana nukleazama
PE20211282A1 (es) Acidos nucleicos para inhibir la expresion de lpa en una celula
JP2018512876A5 (es)
AR044724A1 (es) Promotores del virus de la rizadura amarilla del cestrum
JP2012528572A5 (es)
FR2777909B1 (fr) Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex
JP2015523853A5 (es)
RU2013124422A (ru) Лечение hbv-инфекции
EA201791820A1 (ru) Олигонуклеотидная терапия врожденного амавроза лебера
JP2019511216A5 (es)
AR046598A1 (es) Vectores retrovirales para la administracion de arn de interferencia
CY1108944T1 (el) Θεραπευτικη χρηση των tgf-βητα2 αντινοηματικων ολιγονουκλεοτιδιων
MX9307327A (es) Oligonucleotidos estables.
UY38733A (es) Construcciones de arni para inhibir la expresión de scap y métodos de uso de las mismas
PE20220574A1 (es) Oligonucleotidos gapmer modificados y metodos de uso
CL2020002973A1 (es) Casetes de expresión de a- glucosidasa de ácido optimizado con codón y métodos de uso del mismo
CL2021002842A1 (es) Moléculas inhibidoras de ácido nucleico bicatenario con cadenas de sentido acortadas
Lainé et al. In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication
CL2021000826A1 (es) Ácido ribonucleico bicatenario capaz de suprimir la expresión de c5 de complemento.
CL2022001482A1 (es) Gen cca para la resistencia a los virus
AR107504A1 (es) Secuencia de nucleótidos y método para controlar invasiones de insectos
JP2012085645A5 (es)
CO2021015542A2 (es) Molécula oligomérica de ácido nucleico y uso de esta en el tratamiento de la porfiria aguda intermitente

Legal Events

Date Code Title Description
FB Suspension of granting procedure